RELEReleases

Montefiore Einstein study links wearable glucose monitors to better care

Only 10 percent of insulin-dependent patients currently utilize continuous glucose monitors, yet new research from Montefiore Einstein suggests these devices could drastically reduce hospitalizations. By shifting the technology from specialized endocrinology offices into primary care clinics, doctors are catching blood sugar fluctuations that traditional finger-prick tests consistently miss.

Bio & NewsJuly 6, 2026740 reads0

A study published in JAMA Network Open analyzed over 2,000 patients across 18 Montefiore Medical Group clinics. The data revealed that individuals using continuous glucose monitors (CGMs) were 13 percent less likely to require hospitalization and 18 percent less likely to visit emergency rooms. These wearables provide a continuous stream of data, allowing clinicians to observe how specific meals, stress, or physical activities impact a patient's glucose levels throughout the day.

Lead author Dr. Jovan Milosavljevic and his team are now training primary care staff to prescribe and manage these devices directly. This model moves beyond the limitations of single-point testing, which often fails to capture the 24/7 nature of diabetes management. By integrating CGMs into routine visits, clinicians can now make evidence-based treatment decisions derived from comprehensive, real-world data rather than isolated snapshots.

Comments (0)

Leave a comment

No comments yet. Be the first!